Most frequent cause of drug-related problems: inappropriate dosing
According to a recently published study, inappropriate dosing in neonates is the most frequent cause of drug-related problems. Even though the neonatal intensive care unit had dosing guidelines for all drugs. This was also the case in our study on prescribing errors at the University Children's Hospital Zurich a few years ago. In the meantime, however, the University Children's Hospital Zurich is relying on a sophisticated "clinical decision support tool" to reduce medication errors.
Dosing errors in children could be avoided with "clinical decision support"
Standalone databases are not enough to protect children from dosing errors - pediatricians need a "clinical decision support".
A remarkable study by Gildon BL et al. shows that clinical information systems in children's clinics do not sufficiently meet the requirements of electronic prescribing - and thus errors that could have been avoided are not avoided.
Accordingly, our youngest patients continue to suffer unnecessarily from partially serious consequences of medication errors.
The authors note the following: The use of indication specific dosing and the inclusion of weight based dosing recommendations and calculations would eliminate the majority of dosing errors.
Media release of the Children's Hospital Zurich on the launch of PEDeDose
Dosing drugs for children is difficult. The Children's Hospital Zurich has therefore founded a subsidiary - PEDeus - which has developed «PEDeDose». The online tool calculates the correct dosage for each child individually.
Our vision is to make medication safer for children.
More information about "PEDeDose" can be found in the attached media release.
Short Symposium on April 4, 2019
PEDeus invites you to a short symposium about "For safe medication in children". Detailed information can you find in our invitation flyer.
We are looking forward to your registration at info(at)pedeus(dot)ch!
The short symposium is accredited as SGP continuing education (2 SGP credits) and as FPH continuing education (12.5 FPH points in Hospital Pharmacy and Clinical Pharmacy).
As of today, we'll be appearing in a new look. We have brought our website up to date so that you can find all the relevant information about us and our services with just a few clicks and in an appealing form.
At Congress for Drug Information (Kongress für Arzneimittelinformation)
Together with the company Dosing, PEDeus organised a morning symposium at ADKA Congress for Drug Information in Cologne with the title "PEDeDose - for safe and efficient drug therapy in children". We thank all participants for the great interest!
Pre-launch of PEDeDose at the University Children's Hospital Zurich
We successfully launched PEDeDose at the Children's Hospital Zurich. Their medical staff can now access our tool via web service. We are already working on integrating PEDeDose directly into the "CGM Clinical" clinic information system of the children's hospital in order to make access even easier for healthcare professionals.
PEDeDose notified to Swissmedic
Good news: PEDeDose is notified as a medical device (class 1) to Swissmedic.
PEDeus is founded
The University Children's Hospital Zurich is committed to the safe use of drugs. In order to further develop this important aspect in the therapy of children, the hospital has founded a subsidiary today: PEDeus AG. PEDeus, which stands for "Pediatric Decision Support", aims to make medication safer for children with innovative solutions.